AgingResearch.NewsJoin free

No phaseNot yet recruiting

Outcomes of an Optimized Workflow With PulseSelect Pulsed Field Ablation (PFA) System in Paroxysmal and Persistent Atrial Fibrillation (NEXT PULSE)

Sponsor
Medtronic Cardiac Ablation Solutions (Industry)
Enrolment
320 planned
Conditions
Paroxysmal Atrial Fibrillation (PAF); Persistent Atrial Fibrillation
Interventions
PulseSelect Pulse Field Ablation (PFA) System
Ages
adults, older adults
Registry
NCT07575828

Full record on ClinicalTrials.gov

From the registry

The NEXT PULSE study is a pre-market, prospective, multi-center, non-randomized, interventional clinical study. Adult subjects with symptomatic paroxysmal or persistent AF who provided consent will be enrolled and treated with the PulseSelect PFA System.

Primary outcomes

  • Safety: Number of Participants with at Least One Primary Safety Event
  • Effectiveness: Number of Participants with Treatment Success

History

  1. Study completion expected

  2. Primary completion expected

  3. Expected to start

  4. Last registry update

  5. Registered